Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multi-dose intravenous tranexamic acid for acute traumatic bleeding
ChiCTR2100051194Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tranexamic acid in Bleeding (2 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoints: hidden blood loss, decline of hemoglobin level and 1 more. Started Sep 2021; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
Bleeding
Beyond the preview
Go deeper on ChiCTR2100051194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051194.